Saint-Denis, France

Philippe Cosquer


Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 43(Granted Patents)


Location History:

  • St. Denis, FR (1979)
  • Saint-Denis, FR (1979 - 1992)

Company Filing History:


Years Active: 1979-1992

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Philippe Cosquer

Introduction

Philippe Cosquer is a notable inventor based in Saint-Denis, France. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds and processes. With a total of four patents to his name, Cosquer's work has implications in pharmaceutical applications.

Latest Patents

Among his latest patents, one focuses on amine compounds. This patent describes a compound selected from the group consisting of N-pentyl-N-phenethyl-3-hydroxyphenethylamine and its non-toxic, pharmaceutically acceptable acid addition salts. These compounds exhibit a remarkably dissociated antagonist affinity for the kappa opiate receptor. Another significant patent involves a novel racemization process. This process outlines the preparation of an ester of chiral acid with a racemic alpha-cyano-3-phenoxybenzyl alcohol by reacting an ester of chiral acid with alpha-cyano-3-phenoxybenzyl alcohol in its optically active forms.

Career Highlights

Philippe Cosquer is currently employed at Roussel Uclaf, where he continues to innovate and contribute to the field of pharmaceuticals. His work at this company has allowed him to explore various chemical processes and compounds that have potential therapeutic applications.

Collaborations

Throughout his career, Cosquer has collaborated with notable colleagues such as Julien Warnant and Jacques Prost-Marechal. These collaborations have likely enriched his research and contributed to the successful development of his patents.

Conclusion

Philippe Cosquer's contributions to the field of chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…